U.S. Senators Todd Young (R-Ind.), Maria Cantwell (D-Wash.), and 28 colleagues introduced bipartisan legislation to improve Medicare coverage for lymphedema patients. The Lymphedema Treatment Act would increase and improve care for Medicare beneficiaries with lymphedema by requiring Medicare Part B to cover physician-prescribed compression therapy garments, which are essential in the effective treatment of lymphedema.
The Lymphedema Treatment Act would close an existing coverage gap and improve care for Medicare beneficiaries with lymphedema by ensuring that Medicare covers physician-prescribed compression therapy items under a new Durable Medical Equipment category. These items include multi-layer compression bandaging systems, custom or standard fit compression garments, non- or low-elastic compression garments and wraps, and other compression items determined by the Secretary of Health and Human Services to be effective in preventing or treating lymphedema.
Lymphedema is an incurable but treatable condition affecting between three and five million Americans. It is a chronic condition caused by injury, trauma, or congenital defects in the lymphatic system. If left untreated or inadequately treated, it can lead to complications including loss of function, disability, and in some cases, death.
The Lymphedema Treatment Act has broad, bipartisan support in Congress. The bill is also supported by a wide range of advocacy groups, including the Lymphedema Advocacy Group, American Medical Association, and the American Cancer Society.